Neobladder Posterior Wall Suspended With Round Ligament of Uterus
1 other identifier
interventional
76
1 country
1
Brief Summary
Objective: to evaluate if the Neobladder posterior wall suspended with round ligament of uterus could improve neobladder empty after radical cystectomy in female patients with bladder cancer compared to present standard neobladder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 7, 2011
CompletedFirst Posted
Study publicly available on registry
January 11, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2020
CompletedMarch 31, 2020
March 1, 2020
8.9 years
January 7, 2011
March 27, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
postvoiding residual urine (PVP)
number of patients with postvoiding residual urine (PVP) more than 100ml
2 years after operation
clean intermittent catheterization(CIC)
number of patients required clean intermittent catheterization(CIC)
2 years after operation
Secondary Outcomes (3)
rate of complication
through study completion, an average of 2 years
urodynamic profile
12 months afer operation
rate of continence of neobladder
12 months after operation
Study Arms (2)
neobladder with round lig
EXPERIMENTALileal neobladder suspened with round ligament
standard neobladder
NO INTERVENTIONconventional standard neobladder
Interventions
Neobladder posterior wall suspended with round ligament of uterus after radical cystectomy in female with bladder cancer
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhiwen Chenlead
Study Sites (1)
Urology Institute of PLA, Southwest Hospital
Chongqing, 400038, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ZhiWen Chen, M.D.
Urology Institute of PLA, Southwest Hospital, Chongqin, China
- PRINCIPAL INVESTIGATOR
HuiXiang Ji, M.D.
Urology Institute of PLA, Southwest Hospital, Chongqin, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Vice director of urological institiute of PLA
Study Record Dates
First Submitted
January 7, 2011
First Posted
January 11, 2011
Study Start
January 1, 2011
Primary Completion
November 8, 2019
Study Completion
March 20, 2020
Last Updated
March 31, 2020
Record last verified: 2020-03